A Phase Ib/IIa Study Assessing the Rapid Onset Characteristics of TLL-018 for Moderate-to-Severe CSU With Inadequate Response to Second-Generation H1 Antihistamines

Clinical trial NCT07665996 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07665996
Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria (CSU)

Start date: 2026-07-15
Primary completion: 2027-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.